ASX - By Stock
|
SNT |
Re:
SNT - General Discussions
|
|
ma420
|
117 |
30K |
3 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
117
|
30K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
771K |
4 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
2.2K
|
771K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ma420
|
2.2K |
771K |
15 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
2.2K
|
771K
|
15
|
|
ASX - By Stock
|
COV |
Re:
Cleo Media Thread
|
|
ma420
|
9 |
4.5K |
2 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
9
|
4.5K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation
|
|
ma420
|
43 |
11K |
4 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
43
|
11K
|
4
|
|
ASX - By Stock
|
COV |
Re:
Ann: Cleo Commences US Regulatory Process with FDA
|
|
ma420
|
19 |
8.1K |
2 |
07/07/24 |
07/07/24 |
ASX - By Stock
|
19
|
8.1K
|
2
|
|
ASX - By Stock
|
SNT |
SNT - General Discussions
|
|
ma420
|
117 |
30K |
8 |
06/07/24 |
06/07/24 |
ASX - By Stock
|
117
|
30K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
ma420
|
168 |
47K |
1 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
168
|
47K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation
|
|
ma420
|
43 |
11K |
3 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
43
|
11K
|
3
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation
|
|
ma420
|
43 |
11K |
11 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
43
|
11K
|
11
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation
|
|
ma420
|
43 |
11K |
5 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
43
|
11K
|
5
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation
|
|
ma420
|
43 |
11K |
4 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
43
|
11K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
ma420
|
168 |
47K |
5 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
168
|
47K
|
5
|
|
ASX - By Stock
|
COV |
Re:
Ann: Cleo Commences US Regulatory Process with FDA
|
|
ma420
|
19 |
8.1K |
1 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
19
|
8.1K
|
1
|
|
ASX - By Stock
|
COV |
Re:
Ann: Cleo Commences US Regulatory Process with FDA
|
|
ma420
|
19 |
8.1K |
1 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
19
|
8.1K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation - equity raising
|
|
ma420
|
10 |
3.1K |
1 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
10
|
3.1K
|
1
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation - equity raising
|
|
ma420
|
10 |
3.1K |
2 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
10
|
3.1K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
ma420
|
168 |
47K |
12 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
168
|
47K
|
12
|
|
ASX - By Stock
|
ILA |
Re:
Ann: Non-binding term sheet signed with BioCryst
|
|
ma420
|
40 |
8.2K |
2 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
40
|
8.2K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation - equity raising
|
|
ma420
|
10 |
3.1K |
2 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
10
|
3.1K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
ma420
|
130 |
37K |
6 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
37K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
ma420
|
130 |
37K |
4 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
37K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
ma420
|
130 |
37K |
2 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
37K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
ma420
|
130 |
37K |
2 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
37K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
ma420
|
130 |
37K |
7 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
130
|
37K
|
7
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Adolescent Recruitment into ACTION3 Clinical Trial
|
|
ma420
|
46 |
20K |
6 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
46
|
20K
|
6
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix to present at Melbourne Twilight Investor Briefing
|
|
ma420
|
95 |
40K |
0 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
95
|
40K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
ma420
|
2.2K |
743K |
23 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
2.2K
|
743K
|
23
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Dimerix to present at Melbourne Twilight Investor Briefing
|
|
ma420
|
95 |
40K |
0 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
95
|
40K
|
0
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation
|
|
ma420
|
43 |
11K |
4 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
43
|
11K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation
|
|
ma420
|
43 |
11K |
3 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
43
|
11K
|
3
|
|
ASX - By Stock
|
BDX |
Re:
BDX Media and Publications
|
|
ma420
|
40 |
8.9K |
6 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
40
|
8.9K
|
6
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation
|
|
ma420
|
43 |
11K |
3 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
43
|
11K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
ma420
|
130 |
37K |
0 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
130
|
37K
|
0
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
ma420
|
130 |
37K |
7 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
130
|
37K
|
7
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
555 |
220K |
23 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
555
|
220K
|
23
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation
|
|
ma420
|
43 |
11K |
2 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
43
|
11K
|
2
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation
|
|
ma420
|
43 |
11K |
4 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
43
|
11K
|
4
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation
|
|
ma420
|
43 |
11K |
7 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
43
|
11K
|
7
|
|
ASX - By Stock
|
SNT |
Re:
Ann: Investor presentation
|
|
ma420
|
43 |
11K |
2 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
43
|
11K
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
11K |
4.0M |
1 |
02/07/24 |
02/07/24 |
General
|
11K
|
4.0M
|
1
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant
|
|
ma420
|
168 |
47K |
14 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
168
|
47K
|
14
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
11K |
4.0M |
1 |
02/07/24 |
02/07/24 |
General
|
11K
|
4.0M
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
ma420
|
555 |
220K |
22 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
555
|
220K
|
22
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ma420
|
11K |
4.0M |
1 |
02/07/24 |
02/07/24 |
General
|
11K
|
4.0M
|
1
|
|
ASX - By Stock
|
BDX |
Re:
BDX Media and Publications
|
|
ma420
|
40 |
8.9K |
2 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
40
|
8.9K
|
2
|
|
ASX - By Stock
|
BDX |
Re:
BDX Media and Publications
|
|
ma420
|
40 |
8.9K |
1 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
40
|
8.9K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - General discussion
|
|
ma420
|
400 |
147K |
10 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
400
|
147K
|
10
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
ma420
|
130 |
37K |
8 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
130
|
37K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race In-person Investor Briefing Invitation Perth
|
|
ma420
|
130 |
37K |
8 |
02/07/24 |
02/07/24 |
ASX - By Stock
|
130
|
37K
|
8
|
|